Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma

enthalten in: Clinical cancer research | 2016

von Ekmekcioglu, S. | Davies, M. | Tanese, K. | +10

Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases

enthalten in: Clinical cancer research | 2016

von Nagarajan, P. | Curry, J. | Ning, J. | +12

Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors

enthalten in: Clinical cancer research | 2015

von Goswami, R. | Patel, K. | Singh, R. | +12

Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma

enthalten in: Clinical cancer research | 2015

von Hong, D. | Kurzrock, R. | Wheler, J. | +16

Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations

enthalten in: Clinical cancer research | 2014

von Bucheit, A. | Chen, G. | Siroy, A. | +9

Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target

enthalten in: Clinical cancer research | 2014

von Chen, G. | Chakravarti, N. | Aardalen, K. | +15

Navigating the Therapeutic Complexity of PI3K Pathway Inhibition in Melanoma

enthalten in: Clinical cancer research | 2013

von Kwong, L. | Davies, M.

Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)

enthalten in: Clinical cancer research | 2013

von Nathanson, K. | Martin, A. | Wubbenhorst, B. | +17

Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

enthalten in: Clinical cancer research | 2013

von Mao, M. | Tian, F. | Mariadason, J. | +15

BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice

enthalten in: Clinical cancer research | 2013

von Liu, C. | Peng, W. | Xu, C. | +18